Serum tetranectin is a significant prognostic marker in ovarian cancer patients-Reference-Cited by-同舟云学术

Serum tetranectin is a significant prognostic marker in ovarian cancer patients

Author:

BEGUM FARAH DIBA¹,HØGDALL ESTRID²³,CHRISTENSEN IB JARLE⁴,KJAER SUSANNE KRÜGER¹²,BLAAKAER JAN⁵,CHRISTENSEN LISE⁶,HØGDALL CLAUS¹

Affiliation:

1. The Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

2. Department of Virus, Hormones and Cancer, Danish Cancer Society, Copenhagen, Denmark

3. Department of Pathology, Herlev University Hospital, Copenhagen, Denmark

4. Finsen Laboratory, Rigshospitalet, Copenhagen Biocenter, Denmark

5. Department of Gynecology and Obstetrics, Aarhus University Hospital, Skejby, Aarhus, Denmark

6. Department of Pathology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Link

Reference35 articles.

2. NORDCAN Version 3.4. Available online at:http://www‐dep.iarc.fr/nordcan.htm. (accessed on May 14 2009).

3. Dansk Gynækologisk Cancer Database Årsrapport 2006–2007. ISSN: 1902–7877.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献